Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: Relationship between <scp>PDA</scp> type and risk of device protrusion into the descending aorta

Masri, Saadieh; El‐Rassi, Issam; Arabi, Mariam; Tabbakh, Anas; Bitar, Fadi

doi:10.1002/ccd.25940

Cited by 14 publications

(23 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[212223] The Liddy group reported an occlusion rate of 98% after 6 months. [22] In our study, we noted a lower immediate occlusion rate (85.7%), and this rate remained the same after 3 months.…”

Section: Discussionmentioning

confidence: 99%

“…group did not report hemolysis among their series. [23] A possible explanation for the hemolysis noted with ADO II devices is the presence of residual PDA flow, exaggerated by the use of heparin and streptokinase for the treatment of arterial thrombosis.…”

Section: Discussionmentioning

confidence: 99%

“…groups reported higher rates of CoA (14.3% and 16%) with ADO II devices without LPA stenosis. [2223]…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Cost-effectiveness analysis of different devices used for the closure of small-to-medium-sized patent ductus arteriosus in pediatric patients

et al. 2017

View full text Add to dashboard Cite

Aims:In this study, we examined the differences in cost and effectiveness of various devices used for the closure of small to medium sized patent ductus arteriosus (PDA).Setting and Design:We retrospectively studied 116 patients who underwent closure of small PDAs between January 2010 and January 2015.Subjects and Methods:Three types of devices were used: the Amplatzer duct occluder (ADO) II, the cook detachable coil and the Nit Occlud coil (NOC). Immediate and late complications were recorded and patients were followed up for 3 months after the procedure.Statistical Methods:All statistical calculations were performed using Statistical Package for the Social Science software. P <0.05 were considered significant.Results:We successfully deployed ADO II devices in 33 out of 35 cases, cook detachable coils in 36 out of 40 cases and NOCs in 38 out of 41 cases. In the remaining nine cases, the first device was unsuitable or embolized and required retrieval and replacement with another device. Eleven patients (9.5%) developed vascular complications and required anticoagulation therapy. Patients who had hemolysis or vascular complications remained longer in the intensive care unit, with consequently higher total cost (P = 0.016). Also, the need for a second device increased the cost per patient.Conclusions:The cook detachable coil is the most cost-effective device for closure of small-to medium-sized PDAs. Calculations of the incremental cost-effectiveness. (ICE) revealed that the Cook detachable coil had less ICE than the ADO II and NOC. The NOC was more effective with fewer complications.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Cost-effectiveness analysis of different devices used for the closure of small-to-medium-sized patent ductus arteriosus in pediatric patients

et al. 2017

View full text Add to dashboard Cite

show abstract

“…In Vietnam, an experienced pediatric cardiologist empirically noticed that tubulartype PDA was more frequently seen in PDA associated with CRS than in general PDA without CRS (Do TN, personal communication). Transcatheter closure of tubular-type PDA has difficulty in stabilizing the prosthesis due to lack of a sufficient ampulla; there is the risk of displacement, embolization, or aortic protrusion [62,63]. To clarify the cardiologist's notion and investigate morphological and hemodynamic characteristics of PDA associated with CRS, a retrospective survey of 108 children with CRS and 290 children with PDA but without CRS was conducted in Ho Chi Minh City (Toizumi et al, under review).…”

Section: Cardiac Diseases Of Congenital Rubella Syndromementioning

confidence: 99%

Clinical manifestations of congenital rubella syndrome: A review of our experience in Vietnam

Toizumi

Dang

et al. 2019

Vaccine

View full text Add to dashboard Cite

Rubella vaccination programs have dramatically reduced the incidence of rubella and congenital rubella syndrome (CRS) in developed countries. However, CRS prevalence is still rising in developing countries where rubella-containing vaccines (RCV) are not included in the immunization program and even in some countries where a part of the population lacks immunity to rubella despite the presence of RCV in the regular immunization program. This review aimed to summarize the clinical features of CRS using data from our studies conducted between 2011 and 2015 in Vietnam, wherein we examined clinical manifestations in Vietnamese children with CRS who were born after the large rubella outbreak of 2011; a series of studies dealing with CRS in North America and Europe after the 1960s epidemic; and those from countries before introduction of RCVs. This review shows that children with CRS have a variety of disabilities such as hearing, visual, developmental, behavioral, cardiac, and endocrine impairments, which have variable severity and may appear in different combinations. Some of these impairments can appear or worsen later in the lives of these children. Physicians should thus complete pediatric, cardiac, auditory, ophthalmologic, and neurologic examinations along with laboratory diagnostic testing soon after birth. These assessments should be repeated during follow-up if congenital rubella infection is suspected in a neonate. Timely intervention for cardiac defects can be lifesaving. Early introduction and continuation of speech, occupational, physical, and behavior therapies and training with appropriate medical interventions by a multidisciplinary team approach are required to maximize quality of life. Highlights: • The incidence of CRS is still rising in developing countries • Children with CRS present with a variety of disabilities • A timely multidisciplinary approach improves the quality of life in children with CRS. • A timely multidisciplinary approach can be lifesaving in some children with CRS.

show abstract

“…1) In recent years, transcatheter closure of PDA has become the gold standard treatment approach in patients weighing >5 kg. [1][2][3] The Amplatzer Duct Occluder (ADO; St. Jude Medical Inc., Minnesota, USA) device has been demonstrated to be useful for closing usual conical-shaped PDAs (Krichenko A). 4) However, left pulmonary artery stenosis and/or aortic obstruction has been shown to be a major problem in low-weight infants.…”

mentioning

confidence: 99%

Transcatheter Closure of a Huge Ductus Arteriosus in a Severely Ill Neonate

et al. 2018

View full text Add to dashboard Cite

Hemodynamically significant patent ductus arteriosus (PDA) in preterm infants increases morbidity and mortality. Here we describe a 12-day-old neonate with a huge PDA who developed pulmonary hemorrhage following disseminated intravascular clotting and multiple organ failure. Medical treatment or surgical ligation could not be performed because of the patient's poor condition. Transcatheter closure using a commercially available device (Amplatzer Vascular Plug II) successfully treated the huge PDA without major complications. The Amplatzer Vascular Plug II approach might become a new option for PDA closure in small infants, including those who are critically ill.

show abstract

Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: Relationship between PDA type and risk of device protrusion into the descending aorta

Abstract: Device closure of PDA using the ADO II is a safe procedure for chosen types of PDA. We demonstrated a novel technique for objective assessment of device protrusion into the descending aorta based on measurable parameters. ADOII device closure of non-conical PDAs warrants closer follow ups.

Cited by 14 publications

References 10 publications

Cost-effectiveness analysis of different devices used for the closure of small-to-medium-sized patent ductus arteriosus in pediatric patients

Cost-effectiveness analysis of different devices used for the closure of small-to-medium-sized patent ductus arteriosus in pediatric patients

Clinical manifestations of congenital rubella syndrome: A review of our experience in Vietnam

Transcatheter Closure of a Huge Ductus Arteriosus in a Severely Ill Neonate

Contact Info

Product

Resources

About